RESPONSE OF PSORIASIS TO N-PHOSPHONACETYL-L-ASPARTATE

Robert H. Earhart; Ronald C. Deconti; Joseph Rubin; Takao Ohnuma

doi:10.1016/S0140-6736(81)92419-3

RESPONSE OF PSORIASIS TO N-PHOSPHONACETYL-L-ASPARTATE

Robert H. Earhart
, Ronald C. Deconti
, Joseph Rubin
, Takao Ohnuma

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	1257-1258
Number of pages	2
Journal	The Lancet
Volume	317
Issue number	8232
DOIs	https://doi.org/10.1016/S0140-6736(81)92419-3
State	Published - 6 Jun 1981
Externally published	Yes

Access to Document

10.1016/S0140-6736(81)92419-3

Cite this

@article{16158f2ac1474f1bafdb0549ea6eced3,

title = "RESPONSE OF PSORIASIS TO N-PHOSPHONACETYL-L-ASPARTATE",

author = "Earhart, \{Robert H.\} and Deconti, \{Ronald C.\} and Joseph Rubin and Takao Ohnuma",

note = "Funding Information: R. H. E. is the recipient of a junior clinical faculty fellowship from the American Cancer Society. These observations were made in the course of studies sponsored by the Eastern Cooperative Oncology Group, supported in part by U.S. P.H.S. grant 21115 from the National Cancer Institute, by the Mayo Clinic, supported by contract CM 97268 from the National Cancer Institute and by the Mount Sinai Medical Center, supported by contract N01-CM-97295 and U.S. P.H.S. grant CA-15936 from the National Cancer Institute.",

year = "1981",

month = jun,

day = "6",

doi = "10.1016/S0140-6736(81)92419-3",

language = "English",

volume = "317",

pages = "1257--1258",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "8232",

}

TY - JOUR

T1 - RESPONSE OF PSORIASIS TO N-PHOSPHONACETYL-L-ASPARTATE

AU - Earhart, Robert H.

AU - Deconti, Ronald C.

AU - Rubin, Joseph

AU - Ohnuma, Takao

N1 - Funding Information: R. H. E. is the recipient of a junior clinical faculty fellowship from the American Cancer Society. These observations were made in the course of studies sponsored by the Eastern Cooperative Oncology Group, supported in part by U.S. P.H.S. grant 21115 from the National Cancer Institute, by the Mayo Clinic, supported by contract CM 97268 from the National Cancer Institute and by the Mount Sinai Medical Center, supported by contract N01-CM-97295 and U.S. P.H.S. grant CA-15936 from the National Cancer Institute.

PY - 1981/6/6

Y1 - 1981/6/6

UR - https://www.scopus.com/pages/publications/0019427702

U2 - 10.1016/S0140-6736(81)92419-3

DO - 10.1016/S0140-6736(81)92419-3

M3 - Letter

C2 - 6112581

AN - SCOPUS:0019427702

SN - 0140-6736

VL - 317

SP - 1257

EP - 1258

JO - The Lancet

JF - The Lancet

IS - 8232

ER -